Home › NCT06590285

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation

Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation (DREAM-BMT)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Male or female patients aged 18 or older at the time of study informed consent.
* Have plan to undergo alloHSCT from any donor source using bone marrow, peripheral blood stem cells, or cord blood. Recipients of non-myeloablative, myeloablative and reduced intensity conditioning are eligible.
* Patients have access to digital device capable of downloading study app
* Patients able to read study documents and able to complete informed consent within the study app

Exclusion Criteria:

* Failed prior alloHSCT within the past 6 months

About the study

This randomized, phase I/II, open-label study will investigate the efficacy and safety of an educational sleep intervention vs standard of care in adults undergoing alloHSCT. The randomization target in this pilot phase is 60 patients.

What is being tested

• App-based Educational Intervention (behavioral)

Sponsor: Scripps Health · Participants: 60 · Started: Apr 2, 2026

Contact the study team

• Jake New, MD, PhD · Phone: 858-784-2701

Official record on ClinicalTrials.gov — NCT06590285

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.